Dr. Reddy’s Laboratories has entered an agreement with Takeda Pharma to distribute Takeda’s dengue vaccine QDENGA in India. The companies say the arrangement is subject to local regulatory processes. The Economic Times and The Hindu both report the rollout is targeted for 2027, while Investing.com also describes Dr. Reddy’s role in distributing the vaccine.
The sources differ slightly in emphasis and phrasing. The Hindu and The Economic Times frame the timing as availability in India in the first half of 2027, while Investing.com focuses more directly on Dr. Reddy’s distribution of Takeda’s vaccine. All accounts link the expected launch window to completion of required regulatory steps in India.
Overall, the coverage agrees that Dr. Reddy’s will serve as the distribution partner for QDENGA and that the vaccine’s introduction depends on approvals and implementation within India’s regulatory framework, with a planned 2027 timeframe.
